Immunogenicity and protection induced by Mycobacterium tuberculosis mce-2 and mce-3 mutants in a Balb/c mouse model of progressive pulmonary tuberculosis

Vaccine

Volumn 24, Issue 13, 2006, Pages 2333-2342

  Aguilar, L D ^a   Infante, E ^a   Bianco, M V ^b   Cataldi, A ^b   Bigi, F ^b   Pando, R Hernandez ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^b INSTITUTO NACIONAL DE TECNOLOGÍA AGROPECUARIA INTA   (Argentina)

Author keywords

Experimental tuberculosis; Mce genes; Tuberculosis vaccination

Indexed keywords

BCG VACCINE; CULTURE FILTRATE ANTIGEN; GAMMA INTERFERON; LIVE VACCINE; MYCOBACTERIUM ANTIGEN; MYCOBACTERIUM ANTIGEN AG85; MYCOBACTERIUM ANTIGEN ESAT 6; MYCOBACTERIUM VACCINE; PROTEIN MCE 2; PROTEIN MCE 3; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL PNEUMONIA; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM MUTANT; CELL SUSPENSION; COLONY FORMING UNIT; CONTROLLED STUDY; CYTOKINE PRODUCTION; DELAYED HYPERSENSITIVITY; DISEASE COURSE; EXPERIMENTAL MODEL; GENE EXPRESSION; IMMUNE DEFICIENCY; IMMUNOGENICITY; LUNG TUBERCULOSIS; LYMPH NODE; MALE; MOUSE; MYCOBACTERIOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; SPLEEN; SURVIVAL;

ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BCG VACCINE; MALE; MICE; MICE, INBRED BALB C; MUTATION; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS VACCINES; TUBERCULOSIS, PULMONARY; TUMOR NECROSIS FACTOR-ALPHA; VACCINATION; VACCINES, ATTENUATED; VIRULENCE;

EID: 33344476825     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.11.051     Document Type: Article

References (27)

1. C. Dye, S. Scheele, P. Dolin, V. Pathernia, and M.C. Raviglione Consensus statement: global burden of tuberculosis: estimated incidence, prevalence and mortality by country WHO Global Survaillence and Monitoring Project JAMA 282 1999 677 686
2. A. Pablos-Mendez, M.C. Raviglione, A. Laszlo, N. Bimkin, H.L. Reeder, and F. Bustreo Global surveillance for antituberculosis drug resistance, 1994-1997. World Health Organization - International Union against tuberculosis and lung disease. Working group on anti-tuberculosis drug resistance-surveillance N Engl J Med 338 1998 537 544
3. P.E. Fine Variation in protection by BCG: implications of and for heterologous immunity Lancet 346 1995 1339 1345
4. S. Arruda, G. Bomfim, R. Knights, T. Huima-Byron, and L. Riley Cloning an M. tuberculosis DNA fragment associated with entry and survival inside cells Science 261 1993 1454 1457
5. S.T. Cole, R. Brosch, J. Parkhill, T. Garmier, C. Chincher, and D. Harris Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence Nature 393 1998 537 544
6. S. Bardarov, J. Kriakov, C. Carriere, S. Yu, C. Vaamonde, and R.A. Mc Adam Conditionally replicating mycobacteriophages: a system for transcriptase delivery to Mycobacterium tuberculosis Proc Natl Acad Sci USA 94 1997 10965 10966
7. V. Pelicic, M. Jackson, J.M. Reyrat, W.R. Jacobs, B. Gicquel, and C. Guilhot Efficient allelic exchange and transposon mutagenesis in Mycobacterium tuberculosis Proc Natl Acad Sci USA 94 1997 10955 10960
8. S. Bardarov, S. Bardarov Jr., M.S. Pavelka Jr., V. Sambandamurthy, M. Larsen, and J. Tufariello Specialized transduction: an efficient method for generating marked and unmarked targeted gene disruptions in Mycobacterium tuberculosis, M. bovis Microbiology 148 2002 3007 3017
9. T. Parish, and N.G. Stoker Use of a flexible cassette method to generate a double unmarked Mycobacterium tuberculosis tlyA plcABC mutant by gene replacement Microbiology 146 2000 1969 1975
10. D.A. Smith, T. Parish, N.G. Stoker, and G.J. Bancroft Characterization of auxotrophic mutants of Mycobacterium tuberculosis and their potential as vaccine candidates Infect Immun 69 2001 1142 1150
11. A. Gioffre, E. Infante, D. Aguilar, M.P. Santangelo, L. Klepp, and A. Amadio Mutation in mce genes attenuate M. tuberculosis virulence Microbes Infect 7 2005 325 334
12. N. Shimono, L. Morici, N. Casali, S. Cantrell, B. Sidders, and S. Ehrt Hypervirulent mutant of Mycobacterioum tuberculosis resulting from disruption of the mce1 operon Proc Natl Acad Sci 100 2004 15918 15923
13. M.A. Behr, M.A. Wilson, W.P. Gill, and P. Small Comparative genomics of BCG vaccines by whole-genome DNA microarray Science 284 1999 1520 1523
14. R. Pinto, B.M. Saunders, L.R. Camacho, J. Warwick, B. Gicquel, and J. Triccas Mycobacterium tuberculosis defective in phthiocerol dimycocerosate translocation provides greater protective immunity against tuberculosis than the existing bacilli Calmette-Guerin vaccine J Infect Dis 189 2004 105 112
15. B. Lòpez, L.D. Aguilar, H. Orozco, M. Burger, C. Espitia, and V. Ritacco A marked difference in pathogenesis and immune response induced by different Mycobacterium tuberculosis genotypes Clin Exp Immunol 133 2003 30 37
16. R. Hernández Pando, E.H. Orozco, A. Sampieri, L. Pavón, C. Velasquillo, and S.J. Larriva Correlation between the kinetics of Th1/Th2 cells and pathology in a murine model of experimental pulmonary tuberculosis Immunology 89 1996 26 33
17. R. Hernández Pando, E.H. Orozco, K. Arriaga, A. Sampieri, S.J. Larriva, and M.V. Madrid Analysis of the local kinetics and localization of interleukin 1 alpha, tumor necrosis factor alpha and transforming growth factor beta, during the course of experimental pulmonary tuberculosis Immunology 90 1997 507 516
18. R. Hernández Pando, L. Pavón, K. Arriaga, E.H. Orozco, M.V. Madrid, and G.A.W. Rook Pathogenesis of tuberculosis in mice exposed to low and high doses of an environmental mycobacterial saprophyte before infection Infect Immun 6 1997 84 90
19. C.A. Power, and P.A. Bretscher Mycobacterial doses define the Th1/Th2 nature of the immune response independently of whether immunization is administered by the intravenous, subcutaneous or intradermal route Infect Immun 66 1998 5743 5750
20. R.R. Isberg, and S. Falkow A single genetic locus encoded by Yersinia pseudotuberculosis permits invasion of cultured animal cells by Escherichia coli K-12 Nature 317 6034 1985 262 264
21. C.C. Shepard A comparison of the growth of selected mycobacteria in HeLa, monkey kidney, and human amnion cells in tissue culture J Exp Med 107 1958 237 245
22. Y. Haile, D.A. Caugant, G. Bjune, and H.G. Wiker Mycobacterium tuberculosis cell entry operon (mce) homologs in Mycobacterium other than tuberculosis FEMS Immunol Med Microbiol 33 2002 125 132
23. M.P. Santangelo, J. Goldstein, A. Alito, A. Gioffre, K. Caimi, and O. Zabal Negative transcriptional regulation of the mce3 operon in Mycobacterium tuberculosis Microbiology 148 2002 2997 3006
24. A. Kumar, M. Bose, and V. Brahmachari Analysis of expression profile of mammalian cell entry (mce) operons of Mycobacterium tuberculosis Infect Immun 71 2003 6083 6087
25. C.M. Sassetti, and E.J. Rubin Genetic requirements for mycobacterial survival during infection Proc Natl Acad Sci USA 100 2003 12989 12994
26. A.M. Cooper, D.K. Dalton, T.A. Stewart, J.P. Griffin, D.G. Russel, and I. Orme Disseminated tuberculosis in interferon gamma gene-disrupted mice J Exp Med 178 1993 2243 2247
27. D.B. Young Building a better tuberculosis vaccine Nat Med 9 2003 503 504